Figure 3From: Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: an economic analysis Two-way sensitivity analysis of the effects of the frequency of EGFR mutations and the cost of EGFR genotyping. Back to article page